Skip to main content

Animations

MJFF Publications

1601 - 1610 of 9131 Results
Title
Year
  • Year
  • 2018
  • 2023
  • 2018
  • 2024
  • 2018
  • 2018
  • 2018
  • 2023
  • 2018
  • 2018
  • Summary Details
    OPEN
    Title: Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-28840-w
    Citation Count: 60
  • Summary Details
    OPEN
    Title: Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer disease
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neulet.2023.137330
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Validation of diffusion tensor imaging measures of nigrostriatal neurons in macaques
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0202201
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00706-1
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0203659
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1286-2
    Citation Count: 100
  • Summary Details
    OPEN
    Title: The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awy215
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Biallelic NUDT2 variants defective in mRNA decapping cause a neurodevelopmental disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad434
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Proteomic and functional data sets on synaptic mitochondria from rats with genetic ablation of Parkin
    Journal Name: Data in Brief
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.dib.2018.08.053
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Antibody biomarker for de novo Parkinson disease: attempted validation
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0064-2
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.